Peer Review reports
From: Role of fibroblast growth factor-23 as an early marker of metabolic bone disease of prematurity
Original Submission | ||
---|---|---|
6 Nov 2023 | Submitted | Original manuscript |
Resubmission - Version 2 | ||
Submitted | Manuscript version 2 | |
15 Feb 2024 | Reviewed | Reviewer Report |
13 Apr 2024 | Reviewed | Reviewer Report |
6 May 2024 | Author responded | Author comments - Domingo González-Lamuño |
Resubmission - Version 3 | ||
6 May 2024 | Submitted | Manuscript version 3 |
7 May 2024 | Author responded | Author comments - Domingo González-Lamuño |
Resubmission - Version 4 | ||
7 May 2024 | Submitted | Manuscript version 4 |
9 May 2024 | Reviewed | Reviewer Report |
23 May 2024 | Reviewed | Reviewer Report |
26 May 2024 | Author responded | Author comments - Domingo González-Lamuño |
Resubmission - Version 5 | ||
26 May 2024 | Submitted | Manuscript version 5 |
8 Jun 2024 | Author responded | Author comments - Domingo González-Lamuño |
Resubmission - Version 6 | ||
8 Jun 2024 | Submitted | Manuscript version 6 |
16 Jun 2024 | Author responded | Author comments - Domingo González-Lamuño |
Resubmission - Version 7 | ||
16 Jun 2024 | Submitted | Manuscript version 7 |
Publishing | ||
19 Jun 2024 | Editorially accepted | |
29 Jun 2024 | Article published | 10.1186/s12887-024-04897-7 |
You can find further information about peer review here.